HLA-DR antigens in gastric carcinoma.
Serological HLA typing of 56 gastric carcinoma patients and 53 healthy controls was performed by the long two-stage microlymphocytotoxic test. There was a significantly increased frequency of DR3 antigen (P less than 0.01) in the patients compared to controls. Relative risk analysis revealed a risk of 3.22 for subjects with DR3 antigen for predisposition to gastric carcinoma.